Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:INSP
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares21,350,000
Market Cap$0.00
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) issued its earnings results on Tuesday, August, 7th. The company reported ($0.43) earnings per share for the quarter, topping the consensus estimate of ($0.51) by $0.08. The business had revenue of $10.94 million for the quarter, compared to analyst estimates of $9.30 million. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
What price target have analysts set for INSP?
5 analysts have issued 1 year price targets for Inspire Medical Systems' stock. Their predictions range from $25.00 to $42.00. On average, they expect Inspire Medical Systems' stock price to reach $36.20 in the next year. This suggests that the stock has a possible downside of 18.7%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inspire Medical Systems.
Who are some of Inspire Medical Systems' key competitors?
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
When does Inspire Medical Systems' lock-up period expire?
Inspire Medical Systems' lock-up period expires on Tuesday, October 30th. Inspire Medical Systems had issued 6,750,000 shares in its public offering on May 3rd. The total size of the offering was $108,000,000 based on an initial share price of $16.00. After the end of Inspire Medical Systems' lock-up period, company insiders and major shareholders will be able to sell their shares of the company.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Orbimed Advisors LLC (11.45%), Millennium Management LLC (3.51%), BlackRock Inc. (2.58%), FMR LLC (1.49%), Federated Investors Inc. PA (1.44%) and Redmile Group LLC (0.94%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which major investors are buying Inspire Medical Systems stock?
INSP stock was purchased by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Millennium Management LLC, BlackRock Inc., FMR LLC, Federated Investors Inc. PA, Redmile Group LLC, Gilder Gagnon Howe & Co. LLC and Massachusetts Financial Services Co. MA. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $44.50.
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
